-transparent.png){kind=logo}
Seventeen hypertensive patients receiving guanethidine for therapy were studied to determine the relationship of guanethidine plasma levels to adrenergic blockade. Plasma levels of guanethidine were measured by gas chromatography-mass spectrometry, and adrenergic blockade was defined by determining the venous reflex response to Valsalva maneuver or deep breath. A significant correlation was found between the change in the venous reflex response and the fall in mean standing pressure when guanethidine is given to patients maintained on a sodium restricted diet. A linear relationship was found between dose and plasma guanethidine concentration (p less than 0.0001), but there was a 6-fold interindividual variation in the plasma levels resulting from any given dose. Adrenergic blockade occurred when plasma levels were 8 ng/ml or higher. These results indicate that the large individual variation in dose requirements for the hypotensive effects of guanethidine most likely is not due to requirements for greatly different plasma levels of the drug; that the variation must result from pharmacokinetic determinants of differing plasma levels between individuals or from other factors, such as increased plasma volume, which maintain elevated arterial pressure in the face of adrenergic blockade.
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
May 1975,
Toxicology and applied pharmacology,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
January 1979,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
February 1972,
Archives internationales de pharmacodynamie et de therapie,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
April 1975,
Diabetes,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
September 1970,
British medical journal,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
October 1980,
Research communications in chemical pathology and pharmacology,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
March 1970,
American journal of ophthalmology,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
December 1961,
British journal of pharmacology and chemotherapy,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
November 1999,
The American journal of physiology,
I E Walter, and
J Khandelwal, and
F Falkner, and
A S Nies
January 1972,
Clinical pharmacology and therapeutics,
